Bruker Completes the Acquisition of Neurescence Inc.

Addition Further Strengthens Bruker’s Solutions for Neuroscience Research BILLERICA, Massachusetts – Bruker Corporation today announced that it has completed its acquisition of Neurescence Inc., an innovative provider of ultralight fiber-bundle MultiscopesTM for simultaneous multi-region, optical functional neuroimaging. Bruker anticipates the acquisition will bolster its position as the leading provider of freely behaving animal imaging and [...]

PUROLITE, AN ECOLAB COMPANY, OPENS NEW MANUFACTURING FACILITY IN KING OF PRUSSIA, PENNSYLVANIA

KING OF PRUSSIA, PA, US – Purolite, an Ecolab company, today celebrated the opening of its new pharmaceutical manufacturing facility in King of Prussia, Pa. The 74,000-square-foot plant, which includes an expected 75 new jobs, will produce ion exchange resins for vital healthcare development and pharmaceutical APIs to meet the growing demand for existing and future applications and [...]

Agilent Opens Customer Experience Center Highlighting Genomics and Diagnostics Solutions

New Lexington, Massachusetts facility to provide customer education and collaboration opportunities SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the opening of a new Customer Experience Center (CEC) in Lexington, MA, focused on solutions from Agilent genomics and diagnostics product portfolios. The facility will serve as a regional hub for Agilent representatives to [...]

BIO-TECHNE RELEASES MITOBRILLIANT™ FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced the introduction of MitoBrilliant™ probes.  These novel probes enable the fluorescent labeling and tracking of mitochondria in live and fixed cells. Fluorescent probes that enable highly accurate, sensitive, specific and persistent labeling of mitochondria is critical for a range of demanding scientific and biomedical applications, including high-content screening, [...]

UK Supplier expands to provide Chemically Defined & Serum-Free Cell Media Solutions for the Cell and Gene Therapy Industry

Caption: Cell Media and DMSO-Free Cryopreservation Solutions. BioPharma Dynamics, a leading life sciences solution provider, proudly expand their extensive portfolio for the Cell & Gene Therapy market to offer a range of chemically defined T-Cell Media, DMSO-Free Cryopreservation Solutions, and Recombinant Growth Factors.Suitable for Cell Therapy applications at any stage, the portfolio of cell media products include [...]

Roche announces Brad Moore as president and CEO of Roche Diagnostics North America

INDIANAPOLIS - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the appointment of Brad Moore as president and CEO of Roche Diagnostics North America, effective January 1, 2023. Moore currently serves as senior vice president, Core Lab and Point of Care, within Roche Diagnostics North America. Moore will succeed and report to Matt Sause, who [...]

BIO-TECHNE AND OXFORD NANOPORE TECHNOLOGIES PARTNER TO BRING INNOVATIVE REPRODUCTIVE HEALTH AND CARRIER SCREENING SOLUTIONS TO THE MARKET

New collaboration will develop assays that offer a streamlined workflow for analysing even the most challenging genes. MINNEAPOLIS -- Asuragen, a Bio-Techne brand (NASDAQ: TECH) and Oxford Nanopore Technologies plc (Oxford Nanopore) (LSE: ONT), today announce a collaboration to develop assays designed to deliver more accurate and reliable options for reproductive health and carrier screening. Asuragen will [...]

Scipio bioscience Announces a Single-Cell Grant Program for Four Researchers to Receive a Complete 3′ scRNA-seq Solution Valued up to US$30,000

With the debut of its novel single-cell solution and its first Grant Program, Scipio bioscience is creating an era where scRNA-seq is versatile, flexible, and accessible for every lab Caption: Scipio bioscience's scRNA-seq solution includes the Asteria™ Benchtop Kit and the Cytonaut™ Cloud Analysis Software. Paris, France –  Introduced just six months ago, the Scipio [...]

New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio | ERS Genomics

Dublin, Ireland: ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Cosmo Bio. This is a non-exclusive license agreement granting Japan’s Cosmo Bio access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by Dr. Emmanuelle Charpentier, 2020 Nobel Prize winner for gene-editing, provides access to the foundational CRISPR/Cas9 intellectual property. Over [...]

MGI Cements Its Presence and Contribution in Singapore’s Genomics Landscape at ESMO Asia Congress 2022

SINGAPORE -- MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, will join global and Asian cancer professionals at the ESMO Asia Congress 2022 taking place 2-4 December in Singapore. In addition, MGI will introduce a free trial campaign on its latest sequencer DNBSEQ-G99* for early users [...]

Access IBO on Knowledge Center
Register to Subscribe Login for Access


Register to Subscribe Login for Access

Lost your password? Register